These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3236648)
1. [Changes in phospholipid composition of high density lipoproteins in children as a possible precursor of the development of ischemic heart disease]. Gerasimova EN; Ozerova IN; Aingorn ED; Sipiagina AE; Belokon' NA Kardiologiia; 1988 Sep; 28(9):61-6. PubMed ID: 3236648 [TBL] [Abstract][Full Text] [Related]
2. [Various reasons for changes in the phospholipid composition of high density lipoproteins in hypoalphacholesterolemia]. Gerasimova EN; Nikitin IuP; Ozerova IN; Shcherbakova IA; Sidorenko BA Vopr Med Khim; 1985; 31(3):132-6. PubMed ID: 4024525 [TBL] [Abstract][Full Text] [Related]
3. [Phospholipid content of subfractions of high density lipoproteins in women with angiographically documented coronary arteriosclerosis]. Maĭ FT; Liakishev AA; Polesskiĭ VA; Sidorenko BA; Gerasimova EN Kardiologiia; 1983 Mar; 23(3):33-7. PubMed ID: 6855058 [TBL] [Abstract][Full Text] [Related]
4. Lp(a) and the risk of coronary heart disease. Bihari-Varga M; Kostner G; Czinner A Eur J Epidemiol; 1992 May; 8 Suppl 1():33-5. PubMed ID: 1387093 [TBL] [Abstract][Full Text] [Related]
5. [Phospholipid characteristics of the HDLP2 and HDLP3 composition in dysalphalipoproteinemia]. Gerasimova EN; Pham TM; Suchkova SN; Chepurnenko NV; Polesskiĭ VA Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):86-93. PubMed ID: 7053079 [TBL] [Abstract][Full Text] [Related]
6. [Esterifying activity of the plasma in patients with ischemic heart disease]. Ozerova IN; Gerasimova EN; Maĭ FT; Kurdanov KhA Vopr Med Khim; 1984; 30(5):118-23. PubMed ID: 6528515 [TBL] [Abstract][Full Text] [Related]
7. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
8. [Blood lipids and lipid peroxides in the families of patients with ischemic heart disease]. Davidenkova EF; Shafran MG; Veksler BM; Magracheva EIa; Lozovskiĭ VT Kardiologiia; 1989 Jun; 29(6):10-4. PubMed ID: 2779063 [TBL] [Abstract][Full Text] [Related]
9. [Phospholipid composition of high density lipoproteins in hyperalphalipoproteinemia]. Torkhovskaia TI; Koldaeva AP; Kurchatova SA; Titov VN; Gerasimova EN Vopr Med Khim; 1977; (6):768-73. PubMed ID: 202089 [TBL] [Abstract][Full Text] [Related]
10. [Newly developed stenocardia: effect of intensive physical training on the lipoprotein spectrum of blood plasma]. Komendat VI; Karasev AV; Olfer'ev AM; Mel'kina OE; Gratsianskiĭ NA Kardiologiia; 1988 Jun; 28(6):60-5. PubMed ID: 3144623 [TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220 [TBL] [Abstract][Full Text] [Related]
12. [Ischemic heart disease: risk factors and the level of high density lipoproteins (alpha-lipoproteins)]. Khaltaev NG Ter Arkh; 1981; 53(1):118-26. PubMed ID: 7013138 [No Abstract] [Full Text] [Related]
13. [Clinico-genealogical characteristics of patients with ischemic heart disease and different disorders of lipid metabolism]. Chernyshov VA; Tseluĭko VI Kardiologiia; 1992 Mar; 32(3):13-7. PubMed ID: 1405202 [TBL] [Abstract][Full Text] [Related]
14. [Blood serum high density lipoproteins in coronary disease]. Halawa B Wiad Lek; 1980 Aug; 33(15):1217-9. PubMed ID: 7003921 [No Abstract] [Full Text] [Related]
15. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease. Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G Angiology; 2008; 59(1):26-35. PubMed ID: 18319219 [TBL] [Abstract][Full Text] [Related]
16. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia]. Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530 [TBL] [Abstract][Full Text] [Related]
17. [The lipid-protein indices of the blood cholesterol transport system in systemic lupus erythematosus]. Alekberova ZS; Popkova TV; Nasonov EL; Reshetniak TM; Ozerova IN; Perova NV Ter Arkh; 1999; 71(5):34-8. PubMed ID: 10399228 [TBL] [Abstract][Full Text] [Related]
18. [Plasma lipoprotein levels and functional status of thrombocytes in patients with ischemic heart disease during treatment with essential phospholipids]. Belousova SS; Bogoslovskaia SI; Silagina LM Kardiologiia; 1985 Sep; 25(9):112-5. PubMed ID: 4079219 [TBL] [Abstract][Full Text] [Related]
19. [Indicators of the atherogenic properties of plasma lipoproteins and coronary atherosclerosis (selective angiography data)]. Perova NV; Shcherbakova IA; Nechaev AS; Nikitina NA; Metel'skaia VA Kardiologiia; 1985 Oct; 25(10):91-5. PubMed ID: 4087659 [TBL] [Abstract][Full Text] [Related]
20. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Schaefer EJ; Zech LA; Schwartz DE; Brewer HB Ann Intern Med; 1980 Aug; 93(2):261-6. PubMed ID: 7406376 [No Abstract] [Full Text] [Related] [Next] [New Search]